share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Mandadi Tilak

CVS Health | 4: Statement of changes in beneficial ownership of securities

西維斯健康 | 4：持股變動聲明
SEC announcement ·  04/04 04:55
牛牛AI助理已提取核心訊息
On April 1, 2024, CVS Health EVP and Chief Technology Officer, Mandadi Tilak, was granted 16,339 shares of common stock (RSU) as part of a transaction with the company. The grant, which was completed on the same day, was issued at no cost to the recipient. Following this transaction, Tilak's direct holdings in CVS Health increased to a total of 82,904 shares of common stock. This event reflects the company's ongoing incentive plans for its executive leadership.
On April 1, 2024, CVS Health EVP and Chief Technology Officer, Mandadi Tilak, was granted 16,339 shares of common stock (RSU) as part of a transaction with the company. The grant, which was completed on the same day, was issued at no cost to the recipient. Following this transaction, Tilak's direct holdings in CVS Health increased to a total of 82,904 shares of common stock. This event reflects the company's ongoing incentive plans for its executive leadership.
2024年4月1日，作爲與該公司交易的一部分，CVS Health執行副總裁兼首席技術官曼達迪·蒂拉克獲得了16,339股普通股（RSU）。這筆補助金於當天完成，免費發放給接受者。在這筆交易之後，蒂拉克在CVS Health的直接持股量增加到總共82,904股普通股。該活動反映了公司對執行領導層的持續激勵計劃。
2024年4月1日，作爲與該公司交易的一部分，CVS Health執行副總裁兼首席技術官曼達迪·蒂拉克獲得了16,339股普通股（RSU）。這筆補助金於當天完成，免費發放給接受者。在這筆交易之後，蒂拉克在CVS Health的直接持股量增加到總共82,904股普通股。該活動反映了公司對執行領導層的持續激勵計劃。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。